-
公开(公告)号:KR1020120067534A
公开(公告)日:2012-06-26
申请号:KR1020100128984
申请日:2010-12-16
Applicant: 한국화학연구원
CPC classification number: C12N15/1003 , C12N9/14 , C12Q1/6806 , C12Q1/706 , G01N33/56983
Abstract: PURPOSE: A method for isolating genome DNA from hepatitis B virus(HBV) is provided to screen a therapeutic agent for HBV and to enable genome DNA quantitation. CONSTITUTION: A method for isolating genome DNA from HBV comprises: a step of adding cell lysis material to cells which produces HBV and centrifuging to prepare supernatant; a step of adding protease to the supernatant; and a step of adding phenol/chloroform/isoamyl alcohol to a lysate to prepare genome DNA. The cells are HepG2.2.15, HepW10 or HepD2. The cell lysis material is a RIPA solution containing 50 mM Tris-HCl(pH 8.0), 0.5 M EDTA, 150 mM NaCl, 1% NP-40 and 1 mM phenylmethansulfonyl fluoride(PMSF). The protease is proteinase K. A method for quantitation of the genome DNA includes PCR, southern blotting, or dot blotting.
Abstract translation: 目的:提供一种从乙型肝炎病毒(HBV)分离基因组DNA的方法,以筛选HBV的治疗剂并使基因组DNA定量。 构成:从HBV分离基因组DNA的方法包括:向产生HBV的细胞中加入细胞裂解物质并离心制备上清液的步骤; 向上清液中加入蛋白酶的步骤; 以及向裂解物中加入苯酚/氯仿/异戊醇以制备基因组DNA的步骤。 细胞为HepG2.2.15,HepW10或HepD2。 细胞裂解物质是含有50mM Tris-HCl(pH8.0),0.5M EDTA,150mM NaCl,1%NP-40和1mM苯基甲磺酰氟(PMSF)的RIPA溶液。 蛋白酶是蛋白酶K.用于定量基因组DNA的方法包括PCR,Southern印迹或斑点印迹。
-
公开(公告)号:KR1020130116155A
公开(公告)日:2013-10-23
申请号:KR1020120118708
申请日:2012-10-24
Applicant: 주식회사 강스템바이오텍 , 서울대학교산학협력단
Abstract: PURPOSE: A method for directly producing functional insulin-producing cells from skin cells is provided to directly convert human somatic cells into insulin-producing cells without dedifferentiation into pluripotent cells and to obtain the insulin-producing cells which normally secrete insulin by glucose stimulation. CONSTITUTION: A method for producing insulin-producing cells comprises the step of promoting transcription of PDX-1 gene in somatic cells which do not produce insulin. The method directly converts the somatic cells into insulin-producing cells without dedifferentiation into cells with stemness. The step for promoting transcription of PDX-1 gene comprises the steps of transfecting cells by SMAD2 and transducing anti-Let7i by culturing the transfected cells for 2-10 days. [Reference numerals] (AA) Smad2 trait infection; (BB) Second day; (CC) FGM medium + 1% BSA; (DD) Anti-Let7i trait infection; (EE) EGM medium + 1% BSA; (FF) Seventh day; (GG) Glucose simulation index
Abstract translation: 目的:提供从皮肤细胞直接产生功能性胰岛素生成细胞的方法,以将人体细胞直接转化成胰岛素产生细胞,而不去分化成多能细胞,并获得通过葡萄糖刺激通常分泌胰岛素的胰岛素产生细胞。 构成:产生胰岛素的细胞的方法包括促进PDX-1基因在不产生胰岛素的体细胞中的转录的步骤。 该方法直接将体细胞转化为产生胰岛素的细胞,而无需去分化成具有干细胞的细胞。 促进PDX-1基因转录的步骤包括通过SMAD2转染细胞并通过培养转染细胞2-10天来转导抗Let7i的步骤。 (附图标记)(AA)Smad2性状感染; (BB)第二天; (CC)FGM培养基+ 1%BSA; (DD)抗let7i性状感染; (EE)EGM培养基+ 1%BSA; (FF)第七天; (GG)葡萄糖模拟指数
-